- NEUTRAL
Quarterly Revenue Moolec Science SA Dec-2025 Quarterly Revenue is $0 Million which is growth of 0% YoY.
- NEUTRAL
Quarterly Net Profit Moolec Science SA Dec-2025 Quarterly Net Profit is $0 Million which is growth of 0% YoY.
4.81-0.01(-0.21%)
1,212
XNAS Volume
XNAS 07 Oct, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Moolec Science SA took place on 07 Oct 2026, for the purpose of Moolec Science SA Third Quarter Earnings Results for 2026See detailsMoolec Science SA quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Moolec Science SA quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Dec '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 | Mar '23 | Dec '22 | Sep '22 | Jun '22 | Mar '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Rev. | - | 2.6 | 1.6 | 1.5 | 2.1 | 0.3 | 1.7 | 0.9 | ||||||
Cost Of Rev. | - | 3.3 | 1.5 | 1.6 | 2 | 0 | 1.5 | - | - | - | - | |||
Gross Profit | - | -0.7 | 0 | -0.1 | 0.1 | 0.2 | 0.2 | - | - | - | - | |||
| - | 1.4 | 2.1 | 2.9 | 2.1 | 2 | 2.5 | 0.4 | 0.4 | 43.2 | 0.7 | 1.3 | 0.5 | ||
Operating Profit | - | -2.1 | -2.1 | -2.9 | -2 | -1.8 | -2.3 | -0.6 | -0.4 | -43.2 | -0.7 | -1.3 | -0.5 | |
| - | -0.4 | -0.2 | -0.2 | 0.8 | -0.2 | 0.2 | 0.8 | 0.1 | -0.3 | 0.7 | -0.7 | |||
Profit Before Tax | - | -2.2 | -1.9 | -3.3 | -1.3 | -2 | -1.8 | -3 | -0.4 | -48 | -0.7 | -1.5 | -1.2 | |
Tax | - | 0.3 | -0 | -0.7 | 0.1 | -0.2 | -0.2 | -0.2 | ||||||
| - | -2.4 | -1.9 | -2.5 | -1.4 | -1.8 | -1.6 | -2.8 | -0.4 | -48 | -0.7 | -1.5 | -1.2 | ||
Diluted NI Avail to Com Stockholders Ann. | - | -2.4 | -1.9 | -2.5 | -1.4 | -1.8 | -1.6 | -2.8 | -0.4 | -48 | -0.7 | -1.5 | -1.2 | |
Basic EPS | - | -9 | -7.5 | -10.5 | -6 | -7.5 | -6 | -4.5 | -1.5 | -191.5 | -2.9 | -6.1 | -4.7 | |
Diluted EPS After ExtraOrdinary | - | -9.8 | -8.8 | -10.1 | -6 | -7.5 | -6.8 | -4.5 | -1.5 | -173.7 | -2.9 | -6.1 | -4.7 | |
Number Of Shares End | - | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
Net Income Continuing Discontinued Operations | - | -2.4 | -1.9 | -2.5 | -1.4 | -1.8 | -1.6 | -2.8 | -0.4 | -48 | -0.7 | -1.5 | -1.2 | |
Normalized Income | - | -2.7 | -2.3 | -2.5 | -1.4 | -1.8 | -1.8 | -2.8 | -0.4 | -43.5 | -0.7 | -1.5 | -1.2 | |
Interest Income | - | 0.4 | 0.4 | 0.4 | - | - | 0.4 | - | - | - | - | - | ||
Interest | - | 0.7 | 0.6 | 0.6 | 0.4 | 0.1 | 0.1 | - | - | - | - | |||
Net Interest Income | - | -0.4 | -0.2 | -0.2 | 0.8 | -0.2 | 0.2 | 0.8 | 0.1 | -0.3 | 0.7 | -0.7 | ||
EBIT | - | -1.5 | -1.4 | -2.7 | -0.9 | -1.9 | -1.7 | -3.1 | -0.4 | -48 | -0.7 | -2.2 | -0.5 | |
EBITDA | - | -1.2 | -1.1 | -2.4 | -0.6 | -1.7 | -1.5 | -2.9 | -0.4 | -48 | -0.7 | -2.2 | -0.5 | |
Reconciled Cost Of Rev. | - | 3.2 | 1.4 | 1.5 | 2 | 0 | 1.5 | - | - | - | - | |||
Reconciled Depr. | - | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 | ||||||
Profit From Continuing Operations | - | -2.4 | -1.9 | -2.5 | -1.4 | -1.8 | -1.6 | -2.8 | -0.4 | -48 | -0.7 | -1.5 | -1.2 | |
Normalized EBITDA | - | -1.5 | -1.4 | -2.3 | -0.6 | -1.7 | -1.7 | -2.9 | -0.4 | -43.5 | -0.7 | -2.2 | -0.5 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Moolec Science SA competitor comparison and performance snapshot within industry
Moolec Science SA annual results: revenue, profit, P&L, and margins as of Jun 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Moolec Science SA Jun-2025 Annual Revenue is $334 Million which is growth of 5830.7% YoY.
- NEGATIVE
Annual Net Profit Moolec Science SA Jun-2025 Annual Net Profit is $-111 Million which is growth of -1424.3% YoY.
| Indicator | Graph | CAGR 3 Yrs | TTM | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 |
|---|---|---|---|---|---|---|---|---|
- | 333.6 | 5.6 | 0.9 | - | ||||
Cost Of Rev. Ann. | - | 207.9 | 5.2 | 1.1 | - | - | ||
Gross Profit Ann. | - | 125.7 | 0.5 | -0.1 | - | - | ||
Operating Exp. Ann. | 226.9% | 129.3 | 9.5 | 49.2 | 3.7 | |||
Operating Profit Ann. | - | -3.5 | -9 | -49.4 | -3.7 | |||
- | -107.4 | 0.3 | 0.5 | - | ||||
Other Exp. Ann. | - | -59.1 | 0.4 | -3.2 | -0.9 | - | ||
PBT Ann. | - | -170 | -8.4 | -52 | -4.5 | - | ||
Tax Ann. | - | 6.6 | -1.1 | -0.2 | - | |||
- | -46.3 | -7.3 | -51.8 | -4.5 | - | |||
Diluted NI Avail to Com Stockholders Ann. | - | -46.3 | -7.3 | -51.8 | -4.5 | - | ||
EPS Ann. | - | -258.7 | -28.5 | -225 | -18.1 | - | ||
Diluted EPS Ann. | - | -258.7 | -28.5 | -225 | -18.1 | - | ||
Number Of Shares End | - | - | 0.3 | 0.3 | 0.3 | - | ||
Total Exp. Ann. | 350% | 337.1 | 14.7 | 50.3 | 3.7 | - | ||
Net Income Continuing Discontinued Operations Ann. | - | -111.5 | -7.3 | -51.8 | -4.5 | - | ||
Normalized Income Ann. | - | -85.2 | -7.7 | -48.6 | -3.7 | - | ||
Interest Income Ann. | - | 0.9 | 1.4 | 0.7 | - | - | ||
Interest Ann. | - | 38.1 | 1.2 | 0.2 | - | |||
EBITDA Ann. | - | -109.7 | -6.2 | -51.7 | -4.5 | - | ||
Reconciled Cost Of Rev. Ann. | - | 196.3 | 4.7 | 1 | - | - | ||
Reconciled Depr. Ann. | - | 22.3 | 1 | 0.1 | - | |||
Profit From Continuing Operations Ann. | - | -176.6 | -7.3 | -51.8 | -4.5 | - | ||
Normalized EBITDA Ann. | - | -82.2 | -6.6 | -48.5 | -3.7 | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
5857.1%
2Y CAGR
1825.3%
Operating Exp. Ann.
1Y CHG
1261.1%
2Y CAGR
62.1%
3Y CAGR
226.9%
Moolec Science SA balance sheet as of Jun 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Total Shareholders Fund Moolec Science SA Jun-2025 Total Shareholders Fund is $-66 Million which is growth of -1067.9% YoY.
- POSITIVE
Total Assets Moolec Science SA Jun-2025 Total Assets is $205 Million which is growth of 488.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 |
|---|---|---|---|---|---|---|---|
229.9% | 204.7 | 34.8 | 24.1 | 5.7 | 5.9 | ||
312.4% | 287.6 | 28 | 14 | 4.1 | 0.6 | ||
- | -66 | 6.8 | 10.1 | 1.6 | 5.3 | ||
Total Capitalization Ann. | - | -46.4 | 18.5 | 10.2 | 1.6 | 5.3 | |
Tangible Assets Ann. | - | -141.2 | -2.4 | 1.3 | -3 | 0.7 | |
Working Capital Ann. | - | -204.9 | 5.6 | -7.3 | -3 | 0.7 | |
Invested Capital Ann. | 383.5% | 180.8 | 21.1 | 12.8 | 1.6 | 5.3 | |
Tangible Book Value Ann. | - | -141.2 | -2.4 | 1.3 | -3 | 0.7 | |
Borrowings Ann. | - | 246.9 | 14.7 | 2.7 | - | - | |
Net Debt Ann. | - | 246 | 8.9 | 0.1 | - | - | |
Share Issued Ann. | 32.6% | 0.7 | 0.3 | 0.3 | 0.3 | 0.3 | |
Number Of Shares End | - | - | 0.3 | 0.3 | 0.3 | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
488.2%
2Y CAGR
191.4%
3Y CAGR
229.9%
Total Current Liabilities Ann.
1Y CHG
2779.3%
2Y CAGR
332.9%
3Y CAGR
286.2%
Moolec Science SA ROE, ROCE, book value, and debt-to-equity ratio as of Jun 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Book Value Per Share Moolec Science SA Book Value Per Share is $13 which is growth of -51.1% YoY.
- NEUTRAL
ROE Moolec Science SA ROE is 0% which is growth of 0% YoY.
| Indicator | Graph | CAGR 3 Yrs | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 |
|---|---|---|---|---|---|---|---|
RoA Ann. % | - | -38.65% | -24.86% | -348.24% | -78.24% | - | |
ROE Ann. % | - | - | -86.42% | -884.50% | -131.27% | - | |
ROIC % | - | - | -11.1 | -22.3 | -94.7 | - | |
OPM Ann. % | - | -1.05% | -160.76% | -5,453.72% | - | - | |
Inventory Turnover Ratio Ann. | - | - | 1.5 | 2.3 | - | - | |
Asset Turnover Ann. % | - | - | 0.2 | 0.1 | - | - | |
Working Capital Turnover Ann. | - | -1.6 | 1 | -0.1 | - | ||
Quick Ratio Ann. | - | - | 0.8 | 0.4 | 0.3 | 2.2 | |
Current Ratio Ann. | - | - | 1.7 | 0.4 | 0.3 | 2.2 | |
Interest Coverage Ratio Ann. | - | - | -6.2 | -324.1 | -2,124.3 | - | |
LT Debt To Equity Ann. | - | - | 1.8 | 0 | - | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Moolec Science SA cash flow: net, operating, investing, and financing flows as of Jun 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Moolec Science SA Jun-2025 Cash From Operating Activity is $4 Million which is growth of 139.0% YoY.
- NEGATIVE
Net Cash Flow Moolec Science SA Jun-2025 Net Cash Flow is $-47 Million which is growth of -1981.4% YoY.
| Indicator | Graph | CAGR 3 Yrs | Jun '25 | Jun '24 | Jun '23 | Jun '22 | Jun '21 |
|---|---|---|---|---|---|---|---|
- | 3.6 | -9.3 | -7.5 | -1.9 | - | ||
- | -36 | 0.1 | -2.3 | - | - | ||
- | -15 | 11.7 | 11.3 | 2 | - | ||
Cash Plus Cash Eqv. End Of Year Ann. | -10.1% | 0.8 | 5.4 | 2.5 | 1.1 | - | |
Net Increase In Cash Plus Cash Eqv.s Ann. | - | -47.4 | 2.5 | 1.4 | 0.1 | - | |
Cash Plus Cash Eqv. Begin Of Year Ann. | 275.6% | 53 | 2.5 | 1.1 | 1 | - | |
Income Tax Paid Supplemental Data Ann. | - | - | - | - | - | - | |
Interest Paid Supplemental Data Ann. | - | - | - | - | - | - | |
Capex Ann. | - | -14.6 | -0.2 | -0.2 | - | - | |
Issuance Of Capital Stock Ann. | - | - | 2.2 | 10 | - | ||
Issuance Of Debt Ann. | - | 403.3 | 13.5 | 2.2 | - | - | |
Repayment Of Debt Ann. | - | -385.5 | -2.6 | -0.9 | - | - | |
Repurchase Of Capital Stock Ann. | - | -0.9 | - | - | - | - | |
Free Cash Flow Ann. | - | -11 | -9.5 | -7.7 | -1.9 | - |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
